Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-01-05 @ 5:57 PM
Study NCT ID:
NCT00721669
Status:
COMPLETED
Last Update Posted:
2013-09-13
First Post:
2008-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors
Sponsor:
ImmunoGen, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IMGN388
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None